As genomic technologies become more accessible, they have the potential to reduce healthcare disparities and improve equity ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning session after the company reported ...